You are here: Home » Economy & Policy » News
Business Standard

Nod to Indian firm to conduct Phase-I clinical trial on Zika vaccine: Govt

The application was on the Zika virus vaccine claiming 100% efficacy in animals for grant of permission to conduct the Phase-I clinical trial, Ashwini Choubey

Press Trust of India  |  New Delhi 

Nod to Indian firm to conduct Phase-I clinical trial on Zika vaccine: Govt

The General (India) has granted permission to an Indian firm to conduct Phase-I clinical trial, in pursuance to its application to the DCG (I) on a vaccine, the government has said. Union for Health and Family Welfare Ashwini Kumar Choubey in the had said that an Indian firm had submitted an application to the "The application was on the vaccine, along with non-clinical (Animal) Toxicity data, claiming 100 per cent efficacy in animals for grant of permission to conduct the Phase-I clinical trial," he said in a written reply to a question. "Based on the evaluation of application, in consultation with the Experts Committee, the DCG (I) has granted permission to conduct the Phase-I clinical trial," Choubey said. On the same day, Anupriya Patel, also Union for Health and Family Welfare, said in a written reply that the (WHO) had declared the to be a Public Health Emergency of International Concern (PHEIC) on February 1, 2016, following the Zika outbreak in and other Latin countries and its association with (microcephaly) in new borns. "Further, the WHO declared that it ceased to be a Public Health Emergency on November 18, 2016," she said. She added that the ministry has a three-pronged action plan on combating the disease, and there are 27 laboratories in the government sector that can test the

First Published: Mon, December 18 2017. 20:54 IST
RECOMMENDED FOR YOU